# Project 2 Airway Potential Hydrogen (pH) in Asthma

> **NCT03617718** · PHASE1,PHASE2 · COMPLETED · sponsor: **Case Western Reserve University** · enrollment: 74 (actual)

## Conditions studied

- Cystic Fibrosis
- Asthma
- Severe Persistent Asthma
- Healthy

## Interventions

- **DRUG:** Glycine Buffer

## Key facts

- **NCT ID:** NCT03617718
- **Lead sponsor:** Case Western Reserve University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-01
- **Primary completion:** 2025-07-16
- **Final completion:** 2025-07-16
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2025-08-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03617718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03617718, "Project 2 Airway Potential Hydrogen (pH) in Asthma". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03617718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*